Ipsen Pharma’s Constitutional Complaint

Clifford Chance acted for Ipsen Pharma GmbH. Ipsen Pharma GmbH has filed a constitutional complaint against the provisions of the latest “austerity laws”, i.e., the Act on...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Macquarie Asset Management’s €175m Investment in SkyNRG to Support Sustainable Aviation Fuels (SAF) Growth

Freshfields advised Macquarie Asset Management, Clifford Chance acted for SkyNRG. Macquarie Asset Management, through its Macquarie GIG Energy Transition Solutions (MGETS) Fund, has made an initial...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here